Skip to content

Clinical trials

Phase 1 Hemorrhagic Fever, Ebola trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Fever, Ebola Phase: Phase 1 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20082
20102
20122
20149
201513
20171
20184
20214
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated5
Unknown status3
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)14
University of Oxford7
Arbutus Biopharma Corporation2
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation2
Jiangsu Province Centers for Disease Control and Prevention2
Sarepta Therapeutics, Inc.2
University of Maryland, Baltimore2
Albert B. Sabin Vaccine Institute1
Auro Vaccines LLC1
BioCryst Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Fever, Ebola41
Hemorrhagic Fevers, Viral8
Marburg Virus Disease4
Filoviridae Infections3
Virus Diseases3
Acquired Immunodeficiency Syndrome1
Angioedemas, Hereditary1
Communicable Diseases1
Creutzfeldt-Jakob Syndrome1
Disseminated Intravascular Coagulation1

Trials

Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.